Jaromir Z.
- Country
- Czechia
- Department
- Klinika plicnich onemocneni a tuberkulozy
Research Overview
- Safety Evaluation of CHF5993 pMDI Formulated with HFA-152a Versus HFA-134a in Moderate to Severe Asthma Patients
- Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid-Dependent Asthma: A Randomized, Double-Blind, Placebo-Controlled Study
- Phase 3 Randomized Double-Blind Study of Camlipixant (BLU-5937) Versus Placebo in Adults with Refractory or Unexplained Chronic Cough
Data & Insights
Has run more than one trial at 84 of 266 partner sites.
Specializations
Respiratory Medicine
Specializes in treating chronic respiratory conditions with a particular focus on various forms of asthma management and chronic cough disorders.
- Refractory Chronic Cough
- Unexplained Chronic Cough
- Moderate to Severe Asthma
Demonstrates expertise in evaluating novel therapeutic approaches for respiratory conditions resistant to conventional treatments.
Therapeutic Innovation
Focuses on investigating advanced treatment modalities including novel drug delivery systems and targeted biological therapies for respiratory disorders.
- Propellant-based Medication Delivery Systems
- Biological Therapeutics
- Oral Corticosteroid Reduction Strategies
Evaluates innovative therapeutic solutions for patients with complex respiratory conditions.
Clinical Management
Specializes in treatment optimization for patients with steroid-dependent respiratory conditions and treatment-resistant airways disease.
- Corticosteroid-Dependent Asthma
- Long-term Disease Management
- Treatment-Resistant Conditions
Develops strategies for improving long-term outcomes in chronic respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.